KBC Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
15,970
+15,000
+1,546% +$1.27M ﹤0.01% 733
2026
Q1
$96K Hold
970
﹤0.01% 1342
2025
Q4
$118K Hold
970
﹤0.01% 1187
2025
Q3
$109K Hold
970
﹤0.01% 1210
2025
Q2
$130K Sell
970
-589
-38% -$64.7K ﹤0.01% 1060
2025
Q1
$105K Hold
1,559
﹤0.01% 1456
2024
Q4
$97K Buy
1,559
+638
+69% +$59.4K ﹤0.01% 1583
2024
Q3
$145K Hold
921
﹤0.01% 1070
2024
Q2
$139K Buy
921
+154
+20% +$18.5K ﹤0.01% 1008
2024
Q1
$57K Hold
767
﹤0.01% 1476
2023
Q4
$61K Hold
767
﹤0.01% 1383
2023
Q3
$42K Buy
+767
New +$55.2K ﹤0.01% 1591

Other funds holding TMDX

KBC Group's TMDX Position: Q2 2026 in Review

KBC Group increased its Transmedics (TMDX) stake by 1,546% in Q2 2026, buying an estimated $1.27M and bringing the position to 15,970 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #733.

KBC Group first reported a position in TMDX in Q3 2023 and has held it in 12 quarters since. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • KBC Group held 15,970 shares of Transmedics worth $1.06M as of Q2 2026.
  • KBC Group bought 15,000 Transmedics shares in Q2 2026, an estimated $1.27M.
  • Transmedics made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #733 holding.
  • KBC Group first reported a position in Transmedics in Q3 2023 and has held it in 12 quarters since.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.